By Najat Kantouar BioNTech said that it has agreed to invest $200 million in Autolus Therapeutics, starting a strategic collaboration to advance its pipeline.
By Najat Kantouar BioNTech said that it has agreed to invest $200 million in Autolus Therapeutics, starting a strategic collaboration to advance its pipeline and expand late-stage programs.
Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the World Health Organization